Skip to content

Clinical trials

Completed Phase 1/2 Hereditary Sensory and Autonomic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 1/2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20103
20131
20161
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati3
Cascadian Therapeutics Inc.2
David Bajor, MD1
EMD Serono Research & Development Institute, Inc.1
Kura Oncology, Inc.1
Massachusetts General Hospital1
Minia University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies11
Tuberous Sclerosis3
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Recurrence2
Squamous Cell Carcinoma of Head and Neck2
Astrocytoma1
Breast Neoplasms1
Carcinoma, Squamous Cell1
Colonic Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.